YY-351

Yuyu Pharma, Inc. · Phase 2 active Small molecule

At a glance

Generic name	YY-351
Also known as	Ginsam
Sponsor	Yuyu Pharma, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

YY-351 CI brief — competitive landscape report
YY-351 updates RSS · CI watch RSS
Yuyu Pharma, Inc. portfolio CI